Medicover AB (publ)
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medicover AB (publ) generated cash of $205,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$73,700,000 last year. Net change in cash is therefore $10,400,000.
Cash Flow
| 2014 | 21.7M | -24.7M | 4.1M |
|---|---|---|---|
| 2015 | 28.7M | -45.6M | 22.6M |
| 2016 | 25.9M | -66.1M | 41.5M |
| 2017 | 50.3M | -53.5M | 31.3M |
| 2018 | 44.4M | -116.1M | 64.6M |
| 2019 | 87.3M | -141.8M | 48.8M |
| 2020 | 156M | -126.3M | -14.1M |
| 2021 | 216.7M | -333.6M | 164.1M |
| 2022 | 170.2M | -184.8M | -24.3M |
| 2023 | 205M | -119.8M | -73.7M |
0RPS.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 40.4M | 81.9M | 46.7M | 34.8M | 38.4M | 45.4M | 18.4M | 17.2M | 11.8M | 10.4M |
Operating activities | ||||||||||
Net income | 23.6M | 19.8M | 143.8M | 37.3M | 33.3M | 34.4M | 28M | 12.3M | 16.7M | 12.9M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 182.4M | 161.9M | 111M | 96.2M | 74.2M | 30.4M | 26.2M | 23.3M | 18M | 18.1M |
Stock-based compensation expense | 9.4M | 9.6M | 6.4M | 4.7M | 1.7M | 0 | 1.1M | 1.8M | 200K | 200K |
| Deferred income tax benefit | 9.4M | 9.6M | 6.4M | 4.7M | 1.7M | 0 | 1.1M | 1.8M | 200K | 200K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -29.1M | -26.7M | -49.5M | -29.3M | -23.4M | 0 | -10.1M | 0 | -12M | 0 |
Inventories | -5.1M | 12.7M | -17.1M | -22M | -1.7M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 29.1M | 26.7M | 49.5M | 29.3M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 205M | 170.2M | 216.7M | 156M | 87.3M | 44.4M | 50.3M | 25.9M | 28.7M | 21.7M |
Investing activities | ||||||||||
Purchases Of Investments | -21M | -6.8M | -184.5M | -53.1M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -110.5M | -140.6M | -102.2M | -72.5M | -63.2M | -41M | -29.4M | -54.3M | -30.8M | -23.6M |
Acquisitions Net | -5.6M | -229.1M | -87.5M | -13.6M | -82.6M | -49.3M | -24.4M | -12.1M | -15.7M | -2.3M |
Cash generated by investing activities | -119.8M | -184.8M | -333.6M | -126.3M | -141.8M | -116.1M | -53.5M | -66.1M | -45.6M | -24.7M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 300K | 141.9M | 0 | 400K | 199.3M | 2.7M | 0 | 0 |
Payments for dividends | -17.9M | -17.8M | -10.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -300K | 0 | -300K | 0 | 0 | -400K | 0 | 0 | 0 | 0 |
Repayments of term debt | -900K | 38.8M | -54.7M | -287.8M | 97.4M | -35.6M | -158.8M | -21.1M | 25.3M | -8M |
Cash used in financing activities | -73.7M | -24.3M | 164.1M | -14.1M | 48.8M | 64.6M | 31.3M | 41.5M | 22.6M | 4.1M |
Net Change In Cash | 10.4M | -41.5M | 35.2M | 11.9M | -3.6M | -7M | 27M | 1.2M | 5.4M | 1.4M |
Cash at end of period | 50.8M | 40.4M | 81.9M | 46.7M | 34.8M | 38.4M | 45.4M | 18.4M | 17.2M | 11.8M |